AstraZeneca, which is listed on the London Stock Exchange, reached out to Gilead last month to gauge its interest, according to a Bloomberg report, but did not discuss terms.
AstraZeneca approaches US rival Gilead to discuss merger
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]